Distribution ofblaTEM,blaSHV,blaCTX-MGenes Among Clinical Isolates ofKlebsiella pneumoniaeat Labbafinejad Hospital, Tehran, Iran
- 1 March 2010
- journal article
- research article
- Published by Mary Ann Liebert Inc in Microbial Drug Resistance
- Vol. 16 (1), 49-53
- https://doi.org/10.1089/mdr.2009.0096
Abstract
Extended-spectrum β-lactamase (ESBL)-producing isolates of Klebsiella pneumoniae have been increasingly recognized in the hospital settings in Iran as well as throughout the world. The aim of this study was to detect and determine the genes encoding the ESBLs including blaTEM, blaSHV, and blaCTX-M groups among the K. pneumoniae isolates at Labbafinejad Hospital by polymerase chain reaction (PCR) and characterize them by direct sequencing of PCR products. Eighty-nine isolates were isolated from patients at different wards during March 2008–March 2009. They were identified as K. pneumoniae using biochemical tests. Susceptibility of isolates to 17 different antimicrobial agents was determined using agar disk diffusion method. The phenotypic confirmatory test was used to screen the isolates for production of ESBLs. To amplify the blaSHV the template DNA was extracted by boiling method. Plasmid DNA was extracted using minipreparation kit and used as template in PCR for detection of blaTEM and blaCTX-M. The selected PCR products were sequenced and analyzed. All 89 strains were susceptible to imipenem. The rates of resistance to different antibiotics were in the following order: aztronam (79.7%), cefexime (67.4%), cefpodoxime (66.2%), cefotaxime (65.1%), ceftazidime (61.7%). The phenotypic confirmatory test detected 62 isolates (69.7%) as ESBL-producing K. pneumoniae. The prevalence of genes encoding ESBLs were as follows: blaTEM 54% (n = 48), blaSHV 67.4% (n = 60), blaCTX-M-I 46.51% (n = 40), and blaCTX-M-III 29% (n = 25). The blaCTX-M-II and blaCTX-M-IV were not detected. All blaTEM types were characterized as blaTEM-1 and all blaCTX-M-I were identified as blaCTX-M-15. The SHV types were characterized as SHV-5, SHV-11, and SHV-12. The rate of ESBL at Labbafinejad Hospital was 25% increase in a 4-year study that ended in March 2009. It appears that blaTEM-1, blaSHV-5, blaSHV-11, blaSHV-12, and blaCTX-M-15 are the dominant ESBLs among the resistant strains of K. pneumoniae in Iran.This publication has 27 references indexed in Scilit:
- Extended-spectrumβ-Lactamases: Implications for the Clinical Laboratory and TherapyAnnals of Laboratory Medicine, 2008
- Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, TurkeyAntimicrobial Agents and Chemotherapy, 2008
- Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae in Bulgarian HospitalsMicrobial Drug Resistance, 2008
- Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15Journal of Antimicrobial Chemotherapy, 2008
- Antibiotic resistance surveillance over a 4-year period (2000–2003) in Turkey: results of the MYSTIC ProgramDiagnostic Microbiology and Infectious Disease, 2007
- Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX‐M genes in EnterobacteriaceaeAPMIS, 2007
- Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Strains in Various Types of Private Health Care CentersAntimicrobial Agents and Chemotherapy, 2007
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- Growing Group of Extended-Spectrum β-Lactamases: the CTX-M EnzymesAntimicrobial Agents and Chemotherapy, 2004
- Are SHV β-Lactamases Universal in Klebsiella pneumoniae ? Antimicrobial Agents and Chemotherapy, 2000